
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across ca... Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.32 | -12.8514056225 | 2.49 | 2.49 | 1.85 | 155590 | 2.01791626 | CS |
4 | 0.04 | 1.8779342723 | 2.13 | 2.89 | 1.85 | 174627 | 2.38290379 | CS |
12 | -0.67 | -23.5915492958 | 2.84 | 3.2 | 1.55 | 168787 | 2.26196896 | CS |
26 | -0.58 | -21.0909090909 | 2.75 | 5.22 | 1.3 | 586074 | 2.9776826 | CS |
52 | -1.73 | -44.358974359 | 3.9 | 7.97 | 1.3 | 338012 | 3.14620436 | CS |
156 | -56.03 | -96.2714776632 | 58.2 | 131.857 | 1.3 | 652023 | 12.67729886 | CS |
260 | -105.021 | -97.9755763077 | 107.191 | 134 | 1.3 | 575058 | 15.57431081 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales